非洲爪蟾卵母细胞分期与选用(基于 Dumont 标准)Oocyte staging & selection (Dumont)

实验技术Protocol

Dumont 标准依据直径、色素沉着与形态特征,将爪蟾卵母细胞分为六个时期(I–VI)。正确分期是微注射、蛋白表达与电生理实验稳定可重复的前提。The Dumont system classifies Xenopus oocytes into six stages (I–VI) by diameter, pigmentation and morphology — the basis for reproducible injection, expression and electrophysiology.

非洲爪蟾卵母细胞 I–VI 期分期图(Dumont 标准)
图:爪蟾卵母细胞 I–VI 期形态(Dumont, 1972)。从左至右直径递增,I 期透明无色素,VI 期体积最大并出现赤道无色素带。Fig: Xenopus oocyte stages I–VI (Dumont, 1972). Diameter increases left to right; stage I is transparent, stage VI is the largest with an equatorial unpigmented band.

分期标准Staging

分期Stage直径Diameter主要特征Features
I50–100 μm胞体透明,无色素Transparent, no pigment
II300–450 μm透明或淡白色Transparent / pale
III450–600 μm表面出现均匀色素Uniform pigment appears
IV600–1000 μm出现深色动物半球与白色植物半球Animal/vegetal hemispheres form
V1000–1200 μm两半球界限清晰,动物半球深黑发亮Clear hemisphere border
VI1200–1300 μm无色素带分隔,体积最大Unpigmented band, largest

实验选用建议Selection

  • 微注射(mRNA/cRNA):推荐 VI 期——体积最大(注射量可至 100 nL)、结构完整、翻译效率高。Injection (mRNA/cRNA): prefer stage VI — largest volume (up to 100 nL), intact, high translation.
  • 电生理(电压钳):推荐 II–III 期——体积小、电容低、噪声低、稳定时间短。Electrophysiology: prefer stage II–III — lower capacitance and noise.

应结合直径测量与形态观察进行分期;保存于含抗生素的 0.1× MMR 中;大细胞注射需控制针径与压力。Combine diameter and morphology; keep in 0.1× MMR with antibiotics; control needle size and pressure.

参考文献References

  1. Dumont JN (1972) Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals. J Morphol 136:153–180.
  2. Goldin AL (1992) Maintenance of Xenopus laevis and oocyte injection. Methods Enzymol 207:266–279.
  3. Sigel E (1990) Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J Membr Biol 117(3):201–221.
← 返回实验技术← Protocols卵母细胞表达服务Oocyte service